Efficiency of inactive vaccines against contagious agalactia in Brazil

This paper aims to evaluate the efficiency of three inactive vaccines against contagious agalactia prepared with samples of Mycoplasma agalactiae isolated in Brazil and different adjuvants. Vaccine 1 adsorbed with aluminum hydroxide was administered in 23 goats (Gc1) and 13 sheep (Gov1); vaccine 2 containing Montanide IMS-2215-VG was administered in 22 goats (Gc2) and 12 sheep (Gov2) and vaccine 3, containing Montanide Gel-01 was administered in 22 goats (Gc3) and 12 sheep (Gov3). All animals were negative for Ma at indirect ELISA and received two doses of 2mL each, subcutaneously, within a 21 day interval. Five animals from each species were used as control. Seventy-five days after the booster, four animals from each vaccinated group and two from the control group were challenged with 5mL of Ma culture containing 10(7)cfu/mL, orally and through immersion of the female's udder in lactation. The serological response was analyzed during vaccination days (0 and 21) and at 51, 81, 111, 141 and 171 days after vaccination. The collection and analysis of the challenged animals were conducted at the day of the challenge (D0) and 7, 14, 21, 28, 35, 42, 49 and 56 days after the challenge. The three vaccines induced the production of antibodies, having no significant statistical difference (p<0.05). Animals from groups Gc1, Gc2 and Gov2 developed higher levels of antibodies, with significant statistical difference compared to the other vaccinated group and control group (p<0.05). After the challenge, the animals from the control presented an increase in regional lymph nodes and conjunctivitis, mastitis and arthritis. In four vaccinated animals, discrete conjunctivitis and congestion of the episcleral veins was observed. It is concluded that vaccines 1 and 2 induced levels of protective antibodies in goats and sheep, sufficient for clinical protection of the animals submitted to the experimental infection, indicating its use on the prevention of contagious agalactia.

Saved in:
Bibliographic Details
Main Authors: Campos,A.C., Azevedo,E.O., Alcântara,M.D.B., Silva,R.B.S., Cordeiro,A.A., Mamede,A.G., Melo,M.A., Rosendo Nascimento,E., Castro,R.S.
Format: Digital revista
Language:English
Published: Universidade Federal de Minas Gerais, Escola de Veterinária 2013
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352013000500018
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0102-09352013000500018
record_format ojs
spelling oai:scielo:S0102-093520130005000182013-10-28Efficiency of inactive vaccines against contagious agalactia in BrazilCampos,A.C.Azevedo,E.O.Alcântara,M.D.B.Silva,R.B.S.Cordeiro,A.A.Mamede,A.G.Melo,M.A.Rosendo Nascimento,E.Castro,R.S. Mycoplasma agalactiae goats sheep immunization ELISA This paper aims to evaluate the efficiency of three inactive vaccines against contagious agalactia prepared with samples of Mycoplasma agalactiae isolated in Brazil and different adjuvants. Vaccine 1 adsorbed with aluminum hydroxide was administered in 23 goats (Gc1) and 13 sheep (Gov1); vaccine 2 containing Montanide IMS-2215-VG was administered in 22 goats (Gc2) and 12 sheep (Gov2) and vaccine 3, containing Montanide Gel-01 was administered in 22 goats (Gc3) and 12 sheep (Gov3). All animals were negative for Ma at indirect ELISA and received two doses of 2mL each, subcutaneously, within a 21 day interval. Five animals from each species were used as control. Seventy-five days after the booster, four animals from each vaccinated group and two from the control group were challenged with 5mL of Ma culture containing 10(7)cfu/mL, orally and through immersion of the female's udder in lactation. The serological response was analyzed during vaccination days (0 and 21) and at 51, 81, 111, 141 and 171 days after vaccination. The collection and analysis of the challenged animals were conducted at the day of the challenge (D0) and 7, 14, 21, 28, 35, 42, 49 and 56 days after the challenge. The three vaccines induced the production of antibodies, having no significant statistical difference (p<0.05). Animals from groups Gc1, Gc2 and Gov2 developed higher levels of antibodies, with significant statistical difference compared to the other vaccinated group and control group (p<0.05). After the challenge, the animals from the control presented an increase in regional lymph nodes and conjunctivitis, mastitis and arthritis. In four vaccinated animals, discrete conjunctivitis and congestion of the episcleral veins was observed. It is concluded that vaccines 1 and 2 induced levels of protective antibodies in goats and sheep, sufficient for clinical protection of the animals submitted to the experimental infection, indicating its use on the prevention of contagious agalactia.info:eu-repo/semantics/openAccessUniversidade Federal de Minas Gerais, Escola de VeterináriaArquivo Brasileiro de Medicina Veterinária e Zootecnia v.65 n.5 20132013-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352013000500018en10.1590/S0102-09352013000500018
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Campos,A.C.
Azevedo,E.O.
Alcântara,M.D.B.
Silva,R.B.S.
Cordeiro,A.A.
Mamede,A.G.
Melo,M.A.
Rosendo Nascimento,E.
Castro,R.S.
spellingShingle Campos,A.C.
Azevedo,E.O.
Alcântara,M.D.B.
Silva,R.B.S.
Cordeiro,A.A.
Mamede,A.G.
Melo,M.A.
Rosendo Nascimento,E.
Castro,R.S.
Efficiency of inactive vaccines against contagious agalactia in Brazil
author_facet Campos,A.C.
Azevedo,E.O.
Alcântara,M.D.B.
Silva,R.B.S.
Cordeiro,A.A.
Mamede,A.G.
Melo,M.A.
Rosendo Nascimento,E.
Castro,R.S.
author_sort Campos,A.C.
title Efficiency of inactive vaccines against contagious agalactia in Brazil
title_short Efficiency of inactive vaccines against contagious agalactia in Brazil
title_full Efficiency of inactive vaccines against contagious agalactia in Brazil
title_fullStr Efficiency of inactive vaccines against contagious agalactia in Brazil
title_full_unstemmed Efficiency of inactive vaccines against contagious agalactia in Brazil
title_sort efficiency of inactive vaccines against contagious agalactia in brazil
description This paper aims to evaluate the efficiency of three inactive vaccines against contagious agalactia prepared with samples of Mycoplasma agalactiae isolated in Brazil and different adjuvants. Vaccine 1 adsorbed with aluminum hydroxide was administered in 23 goats (Gc1) and 13 sheep (Gov1); vaccine 2 containing Montanide IMS-2215-VG was administered in 22 goats (Gc2) and 12 sheep (Gov2) and vaccine 3, containing Montanide Gel-01 was administered in 22 goats (Gc3) and 12 sheep (Gov3). All animals were negative for Ma at indirect ELISA and received two doses of 2mL each, subcutaneously, within a 21 day interval. Five animals from each species were used as control. Seventy-five days after the booster, four animals from each vaccinated group and two from the control group were challenged with 5mL of Ma culture containing 10(7)cfu/mL, orally and through immersion of the female's udder in lactation. The serological response was analyzed during vaccination days (0 and 21) and at 51, 81, 111, 141 and 171 days after vaccination. The collection and analysis of the challenged animals were conducted at the day of the challenge (D0) and 7, 14, 21, 28, 35, 42, 49 and 56 days after the challenge. The three vaccines induced the production of antibodies, having no significant statistical difference (p<0.05). Animals from groups Gc1, Gc2 and Gov2 developed higher levels of antibodies, with significant statistical difference compared to the other vaccinated group and control group (p<0.05). After the challenge, the animals from the control presented an increase in regional lymph nodes and conjunctivitis, mastitis and arthritis. In four vaccinated animals, discrete conjunctivitis and congestion of the episcleral veins was observed. It is concluded that vaccines 1 and 2 induced levels of protective antibodies in goats and sheep, sufficient for clinical protection of the animals submitted to the experimental infection, indicating its use on the prevention of contagious agalactia.
publisher Universidade Federal de Minas Gerais, Escola de Veterinária
publishDate 2013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352013000500018
work_keys_str_mv AT camposac efficiencyofinactivevaccinesagainstcontagiousagalactiainbrazil
AT azevedoeo efficiencyofinactivevaccinesagainstcontagiousagalactiainbrazil
AT alcantaramdb efficiencyofinactivevaccinesagainstcontagiousagalactiainbrazil
AT silvarbs efficiencyofinactivevaccinesagainstcontagiousagalactiainbrazil
AT cordeiroaa efficiencyofinactivevaccinesagainstcontagiousagalactiainbrazil
AT mamedeag efficiencyofinactivevaccinesagainstcontagiousagalactiainbrazil
AT meloma efficiencyofinactivevaccinesagainstcontagiousagalactiainbrazil
AT rosendonascimentoe efficiencyofinactivevaccinesagainstcontagiousagalactiainbrazil
AT castrors efficiencyofinactivevaccinesagainstcontagiousagalactiainbrazil
_version_ 1756395597142687744